Relapsed and/or Refractory Multiple Myeloma

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Description

Receive updates on novel diagnostic and prognostic modalities in plasma cell disorders from world renowned experts in the field, as well as, improve understanding of how to manage newly diagnosed patients with plasma cell disorders, relapsed patients. The online module will also focus on Relapsed and/or Refractory Multiple Myeloma.

Original Release Date: November 1, 2020
Valid Thru: October 31, 2022

Speakers
Sagar Lonial, MD, FACP
Peter Voorhees, MD

Accreditation Statement
Atrium Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement
Atrium Health designates this Internet Enduring Material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

• Analyze the novel diagnostic, prognostic and predictive modalities for plasma cell disorders patients
• Discuss the up-to-date approach for newly diagnosed, relapsed and advanced relapsed/refractory plasma cell disorders patients
• Identify the emerging novel mechanism of action and immunotherapeutic approaches in clinical trials for plasma cell disorders

Contact

Melanie Caughron

Electives